Page 430 - IJB-10-4
P. 430

International Journal of Bioprinting                               Pregabalin impact on 3D neuronal models




            Conflict of interest                               Further disclosure
            The authors declare no conflicts of interest.      Part of the findings have been presented at the conference
                                                               Neuroscience 2023 held in Washington, USA.
            Author contributions
            Conceptualization: Raed I. Felimban, Heba A. Alkhatabi,   References
               Abdulaziz Alsharif, Hamza Habeeballah           1.   Alles SR, Cain SM, Snutch TP. Pregabalin as a pain
            Data  curation: Walaa F. Alsanie, Majid Alhomrani,    therapeutic: beyond calcium channels. Front Cell Neurosci.
               Abdulhakeem S. Alamri, Sherin Abdelrahman,         2020;14:83.
               Charlotte A. E. Hauser, Ahmed Gaber                doi: 10.3389/fncel.2020.00083
            Formal analysis: Walaa F. Alsanie, Majid Alhomrani,   2.   Cross AL, Viswanath O, Sherman Al, Pregabalin I.
               Abdulhakeem S. Alamri, Sherin Abdelrahman,         StatPearls. Treasure Island, FL, USA: StatPearls Publishing;
               Charlotte A. E. Hauser, Ahmed Gaber                2023. Available online: (accessed on 1 June, 2023).
            Funding acquisition: Majid Alhomrani, Walaa F. Alsanie,      https://www.ncbi.nlm.nih.gov/books/NBK470341/
               Charlotte A. E. Hauser, Sherin Abdelrahman      3.   Bidari A, Moazen-Zadeh E, Ghavidel-Parsa B, Rahmani
            Investigation: Yusuf S. Althobaiti, Charlotte A. E. Hauser,   S, Hosseini S, Hassankhani A. Comparing duloxetine and
               Bassem M. Raafat                                   pregabalin for treatment of pain and depression in women
            Methodology: Sherin Abdelrahman, Alexander U. Valle-  with fibromyalgia: an open-label randomized clinical trial.
               Pérez, Majid Alhomrani, Walaa F. Alsanie, Ebtisam   DARU. 2019;27(1):149-158.
               Abdulah Alosimi, Ahmed Gaber                       doi: 10.1007/s40199-019-00257-4
            Project administration: Bassem M. Raafat           4.   Moulin D, Boulanger A, Clark A, et al. Pharmacological
            Software: Walaa F. Alsanie, Abdulhakeem S. Alamri,    management of chronic neuropathic pain: revised consensus
               Ahmed Gaber                                        statement from the Canadian Pain Society. Pain Res Manag.
            Supervision: Walaa F. Alsanie, Charlotte A. E. Hauser,   2014;19(6):328-335.
               Majid Alhomrani, Ahmed Gaber                       doi: 10.1155/2014/754693
            Validation: Yusuf S. Althobaiti, Majid Alhomrani, Walaa   5.   Dworkin RH, Corbin AE, Young JP, et al. Pregabalin for the
               F. Alsanie                                         treatment of postherpetic neuralgia: a randomized, placebo-
            Visualization: Raed I. Felimban, Heba A. Alkhatabi,   controlled trial. Neurology. 2003;60(8):1274-1283.
               Abdulaziz Alsharif, Hamza Habeeballah              doi: 10.1212/01.wnl.0000055433.55136.55
            Writing — original draft preparation: Walaa F. Alsanie,   6.   Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin
               Sherin Abdelrahman                                 relieves symptoms of painful diabetic neuropathy: a
            Writing — review and editing: Walaa F. Alsanie, Sherin   randomized  controlled  trial.  Neurology.  2004;63(11):
               Abdelrahman, Alexander U. Valle-Pérez, Charlotte A.   2104-2110.
               E. Hauser, Ahmed Gaber, Abdulaziz Alsharif         doi: 10.1212/01.wnl.0000145767.36287.a1
                                                               7.   Elgazzar FM, Elseady WS, Hafez AS. Neurotoxic effects of
            Ethics approval and consent to participate            pregabalin dependence on the brain frontal cortex in adult
            The animal experiments were carried out in compliance   male albino rats. Neurotoxicology. 2021;83:146-155.
            with international standards for the use of animals in      doi: 10.1016/j.neuro.2021.01.004
            research. This study received clearance from King Abdulaziz   8.   Morse DC. Embryo‐fetal developmental toxicity studies
            University and was approved by the Taif University Ethics   with pregabalin in mice and rabbits. Birth Defects Res B Dev
            Committees (7-CEGMR-Bioeth).                          Reprod Toxicol. 2016;107(2):85-93.
                                                                  doi: 10.1002/bdrb.21174
            Consent for publication                            9.   Kułak-Bejda A, Waszkiewicz N, Popławska  R, Bejda G.
                                                                  The impact of high doses of pregabalin on pregnancy–case
            Not applicable
                                                                  report. Psychiatry Clin Psychopharmacol. 2019;29(1):97-99.
                                                                  doi: 10.1080/24750573.2018.1505452
            Availability of data
                                                               10.  Cross AL, Viswanath O, Sherman AL. Pregabalin. StatPearls
            All data that support the findings of this study are included   [Internet]; 2021. Available online: (accessed April 17, 2023).
            in the article and supplementary file.                https://www.ncbi.nlm.nih.gov/books/NBK470341/







            Volume 10 Issue 4 (2024)                       422                                doi: 10.36922/ijb.3010
   425   426   427   428   429   430   431   432   433   434   435